Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Infusion for Pain After Herniotomy
NCT03673163Unknown
- Sponsor
- Guangzhou First People's Hospital
- Start
- Nov 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in chronic post-surgical pain (CPSP) and postoperative pain (2 arms), sponsored by Guangzhou First People's Hospital. Primary endpoint: Occurrence of chronic pain at 3 months. Status: unknown.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
chronic post-surgical pain (CPSP)postoperative pain
Beyond the preview
Go deeper on NCT03673163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03673163.